Skip to main content
Guttmacher Institute

Search

  • X
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
  • Contact

Highlights

  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • US policy resources
  • State policy resources
  • International Perspectives on Sexual and Reproductive Health (1975–2020)
  • Perspectives on Sexual and Reproductive Health (1969–2020)

Reports

  • Global
  • United States

Articles

  • Global research
  • US research
  • Policy analysis
  • Guttmacher Policy Review
  • Opinion

Fact Sheets

  • Global
  • United States
  • US State Laws and Policies

Tools

  • Interactive Map: US Abortion Policies and Access After Roe
  • Family Planning Investment Impact Calculator
  • Monthly Abortion Provision Study Dashboard
  • State legislation tracker
  • Public-use data sets

Global

  • Abortion
  • Contraception
  • Pregnancy
  • Teens

US

  • Abortion
  • Contraception
  • Pregnancy
  • Teens

Our Work by Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • Newsletter
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Ways to Give
  • Guttmacher Guardians
  • Guttmacher Legacy Circle
  • Financials
  • Impact Report 2025

Awards & Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship
Donate
Guttmacher Institute
Donate

Highlights

  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • US policy resources
  • State policy resources
  • International Perspectives on Sexual and Reproductive Health (1975–2020)
  • Perspectives on Sexual and Reproductive Health (1969–2020)

Reports

  • Global
  • United States

Articles

  • Global research
  • US research
  • Policy analysis
  • Guttmacher Policy Review
  • Opinion

Fact Sheets

  • Global
  • United States
  • US State Laws and Policies

Tools

  • Interactive Map: US Abortion Policies and Access After Roe
  • Family Planning Investment Impact Calculator
  • Monthly Abortion Provision Study Dashboard
  • State legislation tracker
  • Public-use data sets

Global

  • Abortion
  • Contraception
  • Pregnancy
  • Teens

US

  • Abortion
  • Contraception
  • Pregnancy
  • Teens

Our Work by Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • Newsletter
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Ways to Give
  • Guttmacher Guardians
  • Guttmacher Legacy Circle
  • Financials
  • Impact Report 2025

Awards & Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship
Donate
  • X
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
  • Contact
News Release
October 5, 2006

Guttmacher President Honored for Pivotal Role in Bringing Emergency Contraception to the United States

The International Consortium for Emergency Contraception (ICEC) today honors Dr. Sharon Camp for her role in bringing "the morning-after pill," also known as emergency contraception, into the mainstream of women’s health care worldwide. She organized the ICEC over a decade ago, and subsequently established Women’s Capital Corporation, which brought Plan B emergency contraception to American and Canadian women and filed the application to take the product off prescription in both countries.

Ten years ago, emergency contraception was one of medicine’s best kept secrets. Today, 15 manufacturers worldwide produce emergency contraceptive pills, and products are marketed in more than 100 countries. Plan B has been available in the United States by prescription since it won FDA approval in 1999; last month, the FDA approved over-the-counter availability for women aged 18 and older.

"Emergency contraception is more effective the sooner it is used, so it is critical that women are able to get it quickly, even on weekends and holidays," says Dr. Sharon Camp, president and CEO of the Guttmacher Institute. "The FDA’s recent decision to allow women older than 18 to obtain emergency contraception without a prescription is a huge step in the right direction. The next step is to ensure that more women know about the method, how it works and where to get it, so they can avoid an unwanted pregnancy if their regular contraceptive method fails or they have unprotected sex."

Emergency contraception consists of the same hormone (levonorgestral) found in ordinary birth control pills. When taken in a concentrated dosage within 72 hours after unprotected intercourse, this drug can prevent a pregnancy from occurring. Emergency contraception is not "the abortion pill" (mifepristone or RU-486) and will not affect an established pregnancy.

Printer-friendly version

Share

Media Contact

  • Rebecca Wind

    Guttmacher Institute
    212 248 1953
    [email protected]
Guttmacher Institute

Center facts. Shape policy.
Advance sexual and reproductive rights.®

Donate Now
Newsletter Signup  Contact Us 
  • X
  • Facebook
  • Instagram
  • Youtube
  • LinkedIn
  • Contact

Footer

  • Privacy Policy
  • Accessibility Statement
© 2025 Guttmacher Institute. The Guttmacher Institute is registered as a 501(c)(3) nonprofit organization under the tax identification number 13-2890727. Contributions are tax deductible to the fullest extent allowable.